Perception of Actual Factor Concentrates and Expectations Towards Future Treatment with New Long-Lasting Products - Results of a Survey Among Haemophilia Patients in Germany

被引：0
|
作者：
von Mackensen, Sylvia [1 ]
Heinrich, Struck [2 ]
Kalnins, Werner [2 ]
Oldenburg, Johannes [3 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Inst Med Psychol, Hamburg, Germany
[2] German Haemophilia Soc DHG, Hamburg, Germany
[3] Univ Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 7 条
  • [1] Perception of Actual Factor Concentrates and Expectations Towards Future Treatment with New Long-Lasting Products - Results of a Survey Among Haemophilia Patients in Germany - Analysis of Open Questions
    Kalnins, Werner
    Miesbach, Wolfgang A.
    von Mackensen, Sylvia
    BLOOD, 2015, 126 (23)
  • [2] Expectations and Concerns Towards the Up-Coming New Long-Lasting Products - Results of a Survey Among Haemophilia Patients in Germany
    Von Mackensen, S.
    Struck, H.
    Kalnins, W.
    HAEMOPHILIA, 2016, 22 : 70 - 71
  • [3] How haemophilia patients in Germany perceive their actual treatment and what they expect for future treatment with new long-lasting products
    Mackensen, S., V
    Struck, H.
    Kalnins, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 863 - 863
  • [4] Expectations and concerns towards the up-coming new long-acting products - results of a survey among haemophilia patients in Switzerland
    Von Mackensen, Sylvia
    Hostettler, Lino
    Krucker, Jorg
    Albisetti, Manuela
    HAEMOPHILIA, 2016, 22 : 57 - 57
  • [5] Expectations and Concerns Towards New Extended Half-Life (EHL) Products - Results of Surveys Among Haemophilia Patients from the Dach Region
    von Mackensen, Sylvia
    Kalnins, Werner
    Lino, Hostettler
    Joerg, Krucker
    Albisetti, Manuela
    Weiss, Josef
    Pabinger, Ingrid
    Oldenburg, Johannes
    BLOOD, 2016, 128 (22)
  • [6] Long-lasting clinical and immunological results following treatment with 2-CdA in HCL patients: A five-years survey.
    Lauria, F
    Raspadori, D
    Ventura, MA
    Salvucci, M
    Galleni, P
    Birtolo, S
    Bocchia, M
    Forconi, F
    Tura, S
    BLOOD, 1996, 88 (10) : 2895 - 2895
  • [7] Anti-tumour necrosis factor α therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment
    Naumann, L.
    Huscher, D.
    Detert, J.
    Spengler, M.
    Burmester, G-R
    Buttgereit, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (12) : 1934 - 1936
1